Common antibiotic could boost stroke recovery in major new trial
NCT ID NCT07237048
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding the antibiotic minocycline to standard stroke care can improve survival and reduce disability in adults who have had a moderate stroke. About 1,164 participants will be randomly assigned to receive either minocycline pills for five days plus usual care, or usual care alone. Researchers will track neurological recovery and complications over 90 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBROVASCULAR ACCIDENT (STROKE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maimonides Medical Center
RECRUITINGBrooklyn, New York, 11219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to calm an overactive bladder?
- Electric jolt workouts: a new hope for paralyzed limbs?
- Can video games rebuild arm strength after a stroke?
- Blood's tiny messengers may expose hidden brain injury
- Robots may unlock hidden recovery in Stroke-Damaged arms
- Spinal zaps could reboot breathing after brain injury